Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 8,825 shares at $18.77 ($167K) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Open-market sale of $167k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.77 | 3,454 | $65K | 38.9% |
| 2 | $18.77 | 3,454 | $65K | 38.9% |
| 3 | $19.36 | 1,917 | $37K | 22.3% |
| Total | $18.90 avg | 8,825 | $167K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |